O'Reilly, E. M., Lee, J. W., Lowery, M. A., Capanu, M., Stadler, Z. K., Moore, M. J., Dhani, N., Kindler, H. L., Estrella, H., Maynard, H., Golan, T., Segal, A., Salo‐Mullen, E. E., Yu, K. H., Epstein, A. S., Segal, M., Brenner, R., Do, R. K., Chen, A. P., Tang, L. H., & Kelsen, D. P. (2018). phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild‐type BRCA pancreatic ductal adenocarcinoma. Cancer, 124(7), 1374–1382. http://access.bl.uk/ark:/81055/vdc_100057940108.0x000062